Publication | Closed Access

Expectations for Phase-Appropriate Drug Substance and Drug Product Specifications for Early-Stage Protein Therapeutics

Drug TargetPreclinical Drug EvaluationProtein FoldingEarly-stage Protein TherapeuticsMedicineRational Drug DesignProtein EngineeringDrug Product SpecificationsDrug DevelopmentPharmacologyPhase-appropriate Drug SubstanceBiomolecular EngineeringDrug DiscoveryPharmaceutical Research